Latest topics page 19
Topics ordered by most recent activity across all 71 subcategories.
1,535 topics · page 19 of 52
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Secretagogues and glucose tolerance: the mechanistic concern — what changed since
Secretagogues and glucose tolerance: the mechanistic concern — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I have seen STEP 1 ( N Engl J Med , 2021)…
|
+2 | 6 | 31k | 2mo |
|
Revisiting: The arithmetic of an intermediate dose between two label steps
Revisiting: The arithmetic of an intermediate dose between two label steps Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
|
+41 | 45 | 808 | 2mo |
|
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold?
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand…
|
+14 | 18 | 3.4k | 2mo |
|
Why retatrutide discussion here is more cautious than elsewhere
Why retatrutide discussion here is more cautious than elsewhere I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURMOUNT-OSA ( N Engl J Med , 2024) cited…
|
+7 | 12 | 7.7k | 2mo |
|
Residual solvents and scavengers: what is looked for — what changed since
Residual solvents and scavengers: what is looked for — what changed since — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three…
|
+37 | 41 | 7k | 2mo |
|
Currency conversion and the cost you did not see
Currency conversion and the cost you did not see — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked for.…
|
2 | 44k | 2mo | |
|
Reused chromatograms across lots: how to spot it — what changed since
Reused chromatograms across lots: how to spot it — what changed since — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a…
|
+34 | 39 | 20k | 2mo |
|
Introducing myself: pharmacist, sceptic, reluctant participant
Introducing myself: pharmacist, sceptic, reluctant participant Writing it up because I had to work it out twice and would rather nobody else did. Lower-stakes topic, but the sourcing rule still applies if…
|
+13 | 17 | 23k | 2mo |
|
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. A logistics question, since the…
|
+42 | 46 | 46k | 2mo |
|
Delayed gastric emptying and oral medication absorption: which drugs matter — one year on
On the subject in the title: Delayed gastric emptying and oral medication absorption: which drugs matter — one year on Working notes rather than a conclusion. I have read the maintained page on this and I…
|
3 | 16k | 2mo | |
|
Measurement error in home scales, with a worked standard deviation — the long version
On the subject in the title: Measurement error in home scales, with a worked standard deviation — the long version Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022).…
|
+96 | 105 | 2k | 2mo |
|
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters
On the subject in the title: 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly…
|
+108 | 124 | 27k | 2mo |
|
How this community labels and discusses unrefereed work — the long version
Asking directly, because I could not find a straight answer: How this community labels and discusses unrefereed work — the long version I have seen SURMOUNT-1 ( N Engl J Med , 2022) cited in support of a…
|
+18 | 23 | 21k | 2mo |
|
How to ask about something you suspect is a bad idea
The question in the title: How to ask about something you suspect is a bad idea I will give what I have already checked below so nobody repeats it. Question in the title. Context below, and I have tried to…
|
+81 | 87 | 16k | 2mo |
|
Request declined, with reasoning — what changed since
Posting this under the heading it deserves: Request declined, with reasoning — what changed since Everything below is what sits behind that. Process question about how this site works. I have read the…
|
+34 | 38 | 9.4k | 2mo |
|
Amylin receptor signalling and satiety — what changed since
On the subject in the title: Amylin receptor signalling and satiety — what changed since Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a certificate in…
|
+73 | 78 | 3.5k | 2mo |
|
Coming back to: Washout: how long is long enough, and for what purpose
Posting this under the heading it deserves: Washout: how long is long enough, and for what purpose Everything below is what sits behind that. Working through the identity arithmetic and I would like it…
|
+128 | 139 | 3k | 3mo |
|
Common supplements people ask about, assessed one at a time — a second dataset
Posting this under the heading it deserves: Common supplements people ask about, assessed one at a time — a second dataset Everything below is what sits behind that. Reporting something rather than asking…
|
+97 | 104 | 15k | 3mo |
|
Revisiting: Primary endpoint hierarchies and why order matters
Posting this under the heading it deserves: Revisiting: Primary endpoint hierarchies and why order matters Everything below is what sits behind that. Comparing SURMOUNT-4 ( JAMA , 2024) with SURPASS-2 ( N…
|
+21 | 25 | 46k | 3mo |
|
Second pass at: Why chargeback is not the safety net people assume
Second pass at: Why chargeback is not the safety net people assume Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually…
|
2 | 25k | 3mo | |
|
Reconstitution volumes that produce round numbers, tabulated
Reconstitution volumes that produce round numbers, tabulated — setting out what I have, and where I think it stops being reliable. Practical question with the units stated, because I have seen how quickly…
|
+103 | 112 | 1.7k | 3mo |
|
Fatigue in the first month: how much is the drug and how much is intake
On the subject in the title: Fatigue in the first month: how much is the drug and how much is intake Working notes rather than a conclusion. A question about technique rather than about dose. I have been…
|
4 | 17k | 3mo | |
|
Temperature indicator cards: worth asking for?
Asking directly, because I could not find a straight answer: Temperature indicator cards: worth asking for? Structured report rather than an opinion, following the format the maintainers asked for. Compound:…
|
+2 | 6 | 116 | 3mo |
|
Pre-registering a personal experiment, seriously — a second dataset
Posting this under the heading it deserves: Pre-registering a personal experiment, seriously — a second dataset Everything below is what sits behind that. I have seen STEP 8 ( JAMA , 2022) cited in support of…
|
+60 | 66 | 35k | 3mo |
|
What the published dose-response for semaglutide actually looks like above 2.4 mg
What the published dose-response for semaglutide actually looks like above 2.4 mg — that is the question, and I have not found it answered plainly anywhere I have looked. Session topic: SURMOUNT-4 ( JAMA ,…
|
2 | 10k | 3mo | |
|
Subgroup analyses: pre-specified versus discovered — a second dataset
On the subject in the title: Subgroup analyses: pre-specified versus discovered — a second dataset Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022) with SURPASS-4 ( Lancet ,…
|
+71 | 79 | 906 | 3mo |
|
Publication bias detection and its low power — does this still hold?
The question in the title: Publication bias detection and its low power — does this still hold? I will give what I have already checked below so nobody repeats it. I have seen LEADER ( N Engl J Med , 2016)…
|
+24 | 28 | 2.4k | 3mo |
|
Revisiting: Absolute versus relative contraindications
Revisiting: Absolute versus relative contraindications — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this…
|
+80 | 85 | 7.4k | 3mo |
|
Requesting a translation of an existing page — the long version
Posting this under the heading it deserves: Requesting a translation of an existing page — the long version Everything below is what sits behind that. Process question about how this site works. I have read…
|
+2 | 6 | 5.4k | 3mo |
|
Named, unnamed and unspecified impurities as regulatory categories
On the subject in the title: Named, unnamed and unspecified impurities as regulatory categories Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked.…
|
+10 | 14 | 504 | 3mo |